IBI362, also known as Mazdutide, is a dual GLP-1 and glucagon receptor agonist formulated to tackle obesity and metabolic disease. It functions by reducing appetite and increasing energy expenditure, improving weight and blood sugar outcomes. Obesity-related diseases like type 2 diabetes and hypertension are also addressed through its dual mechanism. Trials suggest efficacy in both diabetic and non-diabetic patients. With obesity rates climbing globally, Mazdutide offers an innovative option that integrates metabolic balance and weight regulation in a single therapeutic approach.
Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Mazdutide by Stealth Labs, consult with your doctor or healthcare professional.
Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/
Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/
Nalisa, D.L., Cuboia, N., Dyab, E., Jackson, I.L., Felix, H.J., Shoki, P., Mubiana, M., Oyedeji-Amusa, M., Azevedo, L. and Jiang, H., 2024. Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology (Lausanne). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911117/
Home
